Pfizer
Suddham Singh is a seasoned professional with extensive experience at Pfizer since October 2004, where roles have included Senior Director, Director, and Senior Principal Scientist, focusing on protein characterization and the development, qualification, and validation of analytical methods for vaccines and antibody-drug conjugates (ADCs). Prior to this, Suddham Singh served as a Principal Research Scientist, engaging in the characterization and development of analytical methods for vaccines utilizing proteins, polysaccharides, and glycoconjugates, and as a Senior Research Scientist, contributing to drug substance analytical method development in vaccine projects. Earlier experience includes a position as a Research Scientist at the University of New Hampshire, specializing in the detailed structural analysis of glycans and glycopeptides through mass spectrometry. Suddham Singh holds a Ph.D. in Chemistry from the University of Delhi.
This person is not in the org chart
This person is not in any teams
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.